Severe cytokine release syndrome resulting in purpura fulminans despite successful response to nivolumab therapy in a patient with pleomorphic carcinoma of the lung: a case report

Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab

(2018) Koichi Sato et al.   LUNG CANCER

Immune-Related Adverse Events Associated with Immune Checkpoint Blockade

(2018) Michael A. Postow et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytokine release syndrome

(2018) Alexander Shimabukuro-Vornhagen et al.   Journal for ImmunoTherapy of Cancer

Hemophagocytic lymphohistiocytosis with immunotherapy: brief review and case report

(2018) Masood Sadaat et al.   Journal for ImmunoTherapy of Cancer

Severe hemophagocytic lymphohistiocytosis in a melanoma patient treated with ipilimumab + nivolumab

(2018) Andrew Hantel et al.   Journal for ImmunoTherapy of Cancer

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non–Small-cell Lung Cancer

(2018) Dwight H. Owen et al.   Clinical Lung Cancer

Nivolumab-induced cytokine-release syndrome in relapsed/refractory Hodgkin's lymphoma: a case report and literature review

(2018) Lingdi Zhao et al.   Immunotherapy

Macrophage activation syndrome: A new complication of checkpoint inhibitors

(2017) Nausicaa Malissen et al.   EUROPEAN JOURNAL OF CANCER

Early Immune-Related Adverse Events and Association with Outcome in Advanced Non–Small Cell Lung Cancer Patients Treated with Nivolumab: A Prospective Cohort Study

(2017) Shunsuke Teraoka et al.   Journal of Thoracic Oncology

Severe cytokine release syndrome in a patient receiving PD-1-directed therapy

(2017) Seth J. Rotz et al.   PEDIATRIC BLOOD & CANCER

Review: Immune-Related Adverse Events With Use of Checkpoint Inhibitors for Immunotherapy of Cancer

(2017) Maria E. Suarez-Almazor et al.   Arthritis & Rheumatology

Ipilimumab-induced thrombotic thrombocytopenic purpura (TTP)

(2017) Jeanelle King et al.   Journal for ImmunoTherapy of Cancer

IL-2 consumption by highly activated CD8 T cells induces regulatory T-cell dysfunction in patients with hemophagocytic lymphohistiocytosis

(2016) Stéphanie Humblet-Baron et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Inhibition of Natural Killer Cell Cytotoxicity by Interleukin-6: Implications for the Pathogenesis of Macrophage Activation Syndrome

(2015) Loredana Cifaldi et al.   Arthritis & Rheumatology

Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome

(2014) Laurence Fardet et al.   Arthritis & Rheumatology

Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment

(2010) Lorraine C. Pelosof et al.   MAYO CLINIC PROCEEDINGS

Inflammatory cytokines inhibit ADAMTS13 synthesis in hepatic stellate cells and endothelial cells

(2008) W. J. CAO et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS